Nanjing Luye Pharmaceutical competitive analysis

Loading summary...

Explore Nanjing Luye Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 7, 2020Risperidone Sustained Release Microsphere Composition1
Jul 17, 2019Risperidone Sustained Release Microsphere Composition2

Latest publications and patents of Nanjing Luye Pharmaceutical New

Explore the latest publications and patents granted to Nanjing Luye Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Nanjing Luye Pharmaceutical

Oct 7, 2020Risperidone Sustained Release Microsphere CompositionOpposition Rejected
Jul 17, 2019Risperidone Sustained Release Microsphere CompositionOpposition Rejected

Latest PTAB cases involving Nanjing Luye Pharmaceutical

Discover the latest PTAB cases involving Nanjing Luye Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nanjing Luye Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NANJING LUYE PHARMACEUTICAL - 3 - -
AERA27 - - -
ALKERMES PHARMA IRELAND6912